중간엽줄기세포(MSC)를 이용한 허혈성 혈관질환 치료를 위한 세포치료제 개발: 기초연구에서 임상연구 = Development of Cell Therapeutics against Ischemic Vascular Diseases Using Mesenchymal Stem Cells: From Bench to Bed

국문 초록 (Abstract)

최근 인구 고령화로 인해 허혈성 심장질환, 허혈성 뇌졸중, 말초 동맥 질환 등의 허혈성 혈관질환의 유병률이 지속적으로 증가하고 있다. 허혈성 질환에 대한 현재 표준화된 치료법은 약물 요법 및 수술을 통한 재관류요법이다. 재관류요법은 손상된 동맥의 기능을 회복시킬 수 있지만 허혈로 인해 손상된 주변 조직의 기능 회복에 있어 효율적이지 않다. 그러므로 허혈 질병을 안전하고 효과적으로 치료하고 주변 조직의 기능을 회복시킬 수 있는 새로운 치료전략의 개발이 필요하다. 이러한 한계를 극복하기 위해 손상된 부위를 재생하는 줄기세포 기반 치료가 허혈성 혈관질환의 유망한 전략으로 연구되어 왔다. 다양한 조직에서 분리할 수 있는 중간엽줄기세포(MSC)는 면역 조절, 혈관 신생 촉진 및 다양한 관련 인자의 분비를 통해 손상된 조직을 재생함으로써 허혈성 질환의 치료에 유망한 것으로 나타났다. 또한, 줄기세포 치료 효과를 높이기 위해 3D 배양법을 이용하거나 세포 프라이밍(Cell Priming)과 같은 MSC 기능을 강화하여 이식 효율을 높이는 새로운 접근법이 연구되고 있다. 이 논문에서는 MSC를 허혈성 질환 치료에 사용하는 다양한 전략을 제공하고 허혈성 부위에서 MSC의 분화(Differentiation), 증식(Proliferation) 및 생착(Engraftment)과 같은 이식의 문제에 대해 논의한다.

참고문헌 (Reference)

1 Steinberg, G. K., "Twoyear safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells(SB623) : a phase 1/2a study" 131 : 1462-1472, 2018

2 Kabat, M., "Trends in mesenchymal stem cell clinical trials 2004-2018 : Is efficacy optimal in a narrow dose range?" 9 : 17-27, 2020

3 Zhao, D., "Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells" 50 : 325-330, 2012

4 Heldman, A. W., "Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy : the TAC-HFT randomized trial" 311 : 62-73, 2014

5 Liew, A., "Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia" 3 : 28-, 2012

6 Yu, J., "The use of human mesenchymal stem cells encapsulated in RGD modified alginate microspheres in the repair of myocardial infarction in the rat" 31 : 7012-7020, 2010

7 Ikhapoh, I. A., "Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells" 6 : 4-, 2015

8 Wu, Y. N., "Substrate topography determines the fate of chondrogenesis from human mesenchymal stem cells resulting in specific cartilage phenotype formation" 10 : 1507-1516, 2014

9 Yu, H., "Stem cell therapy for ischemic heart diseases" 121 : 135-154, 2017

10 Ikhapoh, I. A., "Sry-type HMG box 18 contributes to the differentiation of bone marrow-derived mesenchymal stem cells to endothelial cells" 89 : 87-96, 2015

11 Saqqur, M., "Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke" 38 : 948-954, 2007

12 Kyurkchiev, D., "Secretion of immunoregulatory cytokines by mesenchymal stem cells" 6 : 552-570, 2014

13 Ra, J. C., "Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans" 20 : 1297-1308, 2011

14 Lalu, M. M., "Safety of cell therapy with mesenchymal stromal cells(SafeCell) : a systematic review and meta-analysis of clinical trials" 7 : e47559-, 2012

15 Bartolucci, J., "Safety and efficacy of the intravenous infusion of umbilical cord mesenchymal stem cells in patients with heart failure : a phase 1/2randomized controlled trial(RIMECARD Trial [Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy])" 121 : 1192-1204, 2017

16 Wang, J., "Safety and efficacy of placenta-derived mesenchymal stem cell treatment for diabetic patients with critical limb Ischemia : a pilot study" 129 : 542-548, 2021

17 Hess, D. C., "Safety and efficacy of multipotent adult progenitor cells in acute ischaemic stroke(MASTERS) : a randomised, double-blind, placebo-controlled, phase 2 trial" 16 : 360-368, 2017

18 Su, Y. H., "Safety and effectiveness of intravenous thrombolysis for acute Ischemic stroke outside the coverage of national health insurance in Taiwan" 26 : 3-12, 2017

19 Seifert, A., "Role of Hox genes in stem cell differentiation" 7 : 583-595, 2015

20 Diez-Tejedor, E., "Reparative therapy for acute ischemic stroke with allogeneic mesenchymal stem cells from adipose tissue : a safety assessment : a phase II randomized, double-blind, placebo-controlled, single-center, pilot clinical trial" 23 : 2694-2700, 2014

21 Chullikana, A., "Randomized, double-blind, phase I/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction" 17 : 250-261, 2015

22 Ji, S. T., "Promising therapeutic strategies for mesenchymal stem cell-based cardiovascular regeneration : from cell priming to tissue engineering" 2017 : 3945403-, 2017

23 Noronha, N. C., "Priming approaches to improve the efficacy of mesenchymal stromal cell-based therapies" 10 : 131-, 2019

24 김지용 ; 이재성 ; Yong-seok Han ; 이준희 ; 배인효 ; 윤여민 ; 권상모 ; 이상훈, "Pretreatment with Lycopene Attenuates Oxidative Stress-Induced Apoptosis in Human Mesenchymal Stem Cells" 한국응용약물학회 23 (23): 517-524, 2015

25 Friedenstein, A. J., "Precursors for fibroblasts in different populations of hematopoietic cells as detected by the in vitro colony assay method" 2 : 83-92, 1974

26 El-Ansary, M., "Phase II trial : undifferentiated versus differentiated autologous mesenchymal stem cells transplantation in Egyptian patients with HCV induced liver cirrhosis" 8 : 972-981, 2012

27 Jiang, C. Y., "Optimal time for mesenchymal stem cell transplantation in rats with myocardial infarction" 9 : 630-637, 2008

28 배금석 ; 강성준 ; 박준범 ; 김현수 ; 김대성 ; 박동준, "Neuron-Like Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells" 연세대학교의과대학 52 (52): 401-412, 2011

29 Wakitani, S., "Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine" 18 : 1417-1426, 1995

30 Pittenger, M. F., "Multilineage potential of adult human mesenchymal stem cells" 284 : 143-147, 1999

31 Mackenzie, T. C., "Multilineage differentiation of human MSC after in utero transplantation" 3 : 403-405, 2001

32 Najar, M., "Mesenchymal stromal cells and immunomodulation : A gathering of regulatory immune cells" 18 : 160-171, 2016

33 Herrmann, R., "Mesenchymal stromal cell therapy for steroid-refractory acute and chronic graft versus host disease : a phase 1 study" 95 : 182-188, 2012

34 Ullah, M., "Mesenchymal stromal cell homing : mechanisms and strategies for improvement" 15 : 421-438, 2019

35 Rashed, L. A., "Mesenchymal stem cells pretreated with melatonin ameliorate kidney functions in a rat model of diabetic nephropathy" 96 : 564-571, 2018

36 Sibov, T. T., "Mesenchymal stem cells from umbilical cord blood : parameters for isolation, characterization and adipogenic differentiation" 64 : 511-521, 2012

37 Xu, W., "Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro" 229 : 623-631, 2004

38 Silva, G. V., "Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model" 111 : 150-156, 2005

39 Li, W., "Mesenchymal stem cell-based therapy for stroke : current understanding and challenges" 15 : 628940-, 2021

40 Jeong, H., "Mesenchymal stem cell therapy for Ischemic Heart Disease : Systematic review and metaanalysis" 11 : 1-12, 2018

41 Ascheim, D. D., "Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices" 129 : 2287-2296, 2014

42 Mao, P., "Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3" 110 : 8644-8649, 2013

43 허순철 ; 권양우 ; 박규태 ; 권상모 ; 배순식 ; 박범준 ; 김재호, "Mesenchymal Stem Cell-Mediated Therapy of Peripheral Artery Disease Is Stimulated by a Lamin A-Progerin Binding Inhibitor" 한국지질동맥경화학회 9 (9): 460-473, 2020

44 Shuai, Y., "Melatonin treatment improves mesenchymal stem cells therapy by preserving stemness during long-term in vitro expansion" 6 : 1899-1917, 2016

45 Gralla, J., "Mechanical thrombolysis and stenting in acute ischemic stroke" 43 : 280-285, 2012

46 Lu, D., "Long-term outcomes of BMMSC compared with BMMNC for treatment of critical limb Ischemia and foot ulcer in patients with diabetes" 28 : 645-652, 2019

47 Lee, S. C., "Lipopolysaccharide preconditioning of adipose-derived stem cells improves liver-regenerating activity of the secretome" 6 : 75-, 2015

48 Honmou, O., "Intravenous administration of auto serum-expanded autologous mesenchymal stem cells in stroke" 134 : 1790-1807, 2011

49 Schmehl, J., "Intravascular application of labelled cell spheroids : an approach for Ischemic peripheral artery disease" 22 : 6831-, 2021

50 Guijarro, D., "Intramyocardial transplantation of mesenchymal stromal cells for chronic myocardial ischemia and impaired left ventricular function : Results of the MESAMI 1 pilot trial" 209 : 258-265, 2016

51 Williams, A. R., "Intramyocardial stem cell injection in patients with ischemic cardiomyopathy : functional recovery and reverse remodeling" 108 : 792-796, 2011

52 Kouroupis, D., "Infrapatellar fat pad-derived mesenchymal stem cell-based spheroids enhance their therapeutic efficacy to reverse synovitis and fat pad fibrosis" 12 : 44-, 2021

53 Hou, L., "Induction of umbilical cord blood mesenchymal stem cells into neuron-like cells in vitro" 78 : 256-261, 2003

54 Park, B. W., "In vivo priming of human mesenchymal stem cells with hepatocyte growth factor-engineered mesenchymal stem cells promotes therapeutic potential for cardiac repair" 6 : eaay6994-, 2020

55 Tebebi, P. A., "Improving the therapeutic efficacy of mesenchymal stromal cells to restore perfusion in critical limb ischemia through pulsed focused ultrasound" 7 : 41550-, 2017

56 Liu, C. B., "Human umbilical cord-derived mesenchymal stromal cells improve left ventricular function, perfusion, and remodeling in a porcine model of chronic myocardial Ischemia" 5 : 1004-1013, 2016

57 Yin, F., "Human umbilical cord mesenchymal stem cells ameliorate liver fibrosis in vitro and in vivo : From biological characteristics to therapeutic mechanisms" 11 : 548-564, 2019

58 Zuk, P. A., "Human adipose tissue is a source of multipotent stem cells" 13 : 4279-4295, 2002

59 Eseonu, O. I., "Homing of mesenchymal stem cells: mechanistic or stochastic? Implications for targeted delivery in arthritis" 54 : 210-218, 2015

60 De Becker, A., "Homing and migration of mesenchymal stromal cells : How to improve the efficacy of cell therapy?" 8 : 73-87, 2016

61 Chung, N., "HOX gene analysis of endothelial cell differentiation in human bone marrow-derived mesenchymal stem cells" 36 : 227-235, 2009

62 Khazaei, M., "Former antiplatelet drug administration and consequences of intravenous thrombolysis in acute ischemic stroke" 28 : 53-56, 2020

63 Zhang, K., "Enhanced therapeutic effects of Mesenchymal stem cell-derived exosomes with an injectable hydrogel for Hindlimb Ischemia treatment" 10 : 30081-30091, 2018

64 Bago, J. R., "Endothelial differentiation of adipose tissue-derived mesenchymal stromal cells in glioma tumors : implications for cell-based therapy" 21 : 1758-1766, 2013

65 Gutierrez-Fernandez, M., "Effects of intravenous administration of allogenic bone marrow-and adipose tissue-derived mesenchymal stem cells on functional recovery and brain repair markers in experimental ischemic stroke" 4 : 11-, 2013

66 Gao, W. H., "Effectiveness of umbilical cord mesenchymal stem cells in patients with critical limb ischemia" 153 : 341-346, 2019

67 Florea, V., "Dose Comparison Study of Allogeneic Mesenchymal Stem Cells in Patients With Ischemic Cardiomyopathy(The TRIDENT Study)" 121 : 1279-1290, 2017

68 Haack-Sorensen, M., "Direct intramyocardial mesenchymal stromal cell injections in patients with severe refractory angina : one-year follow-up" 22 : 521-528, 2013

69 Yang, J., "Differentiation potential of human mesenchymal stem cells derived from adipose tissue and bone marrow to sinus node-like cells" 5 : 108-113, 2012

70 Sangiorgi, B., "DSP30 enhances the immunosuppressive properties of mesenchymal stromal cells and protects their suppressive potential from lipopolysaccharide effects : A potential role of adenosine" 18 : 846-859, 2016

71 Choudhery, M. S., "Comparison of human mesenchymal stem cells derived from adipose and cord tissue" 15 : 330-343, 2013

72 Hare, J. M., "Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy : the POSEIDON randomized trial" 308 : 2369-2379, 2012

73 Urrutia, D. N., "Comparative study of the neural differentiation capacity of mesenchymal stromal cells from different tissue sources : An approach for their use in neural regeneration therapies" 14 : e0213032-, 2019

74 Pievani, A., "Comparative analysis of multilineage properties of mesenchymal stromal cells derived from fetal sources shows an advantage of mesenchymal stromal cells isolated from cord blood in chondrogenic differentiation potential" 16 : 893-905, 2014

75 Lei, H., "Comparative analysis of mesenchymal stem cells from adult mouse adipose, muscle, and fetal muscle" 40 : 885-892, 2013

76 Huang, Z., "Chondrogenesis of human bone marrow mesenchymal stromal cells in highly porous alginate-foams supplemented with chondroitin sulfate" 50 : 160-172, 2015

77 Bartunek, J., "Cardiopoietic cell therapy for advanced ischaemic heart failure : results at 39weeks of the prospective, randomized, double blind, shamcontrolled CHART-1 clinical trial" 38 : 648-660, 2017

78 Mathiasen, A. B., "Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure : a randomized placebo-controlled trial(MSC-HF trial)" 36 : 1744-1753, 2015

79 Jaillard, A., "Autologous mesenchymal stem cells improve motor recovery in subacute Ischemic stroke : a randomized clinical trial" 11 : 910-923, 2020

80 Connick, P., "Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis : an open-label phase 2a proofof-concept study" 11 : 150-156, 2012

81 Bang, O. Y., "Autologous mesenchymal stem cell transplantation in stroke patients" 57 : 874-882, 2005

82 Qayyum, A. A., "Autologous adipose-derived stromal cell treatment for patients with refractory angina(MyStromalCell Trial) : 3-years follow-up results" 17 : 360-, 2019

83 Chang, D., "Application of mesenchymal stem cell sheet to treatment of ischemic heart disease" 12 : 384-, 2021

84 Smadja, D. M., "Angiogenic potential of BM MSCs derived from patients with critical leg ischemia" 47 : 997-1000, 2012

85 Premer, C., "Allogeneic Mesenchymal stem cells restore endothelial function in heart failure by stimulating endothelial progenitor cells" 2 : 467-475, 2015

86 Li, S., "Advances in the treatment of Ischemic Diseases by mesenchymal stem cells" 2016 : 5896061-, 2016

87 Gupta, P. K., "Administration of adult human bone marrow-derived, cultured, pooled, allogeneic mesenchymal stromal cells in critical limb Ischemia due to Buerger's disease : Phase II study report suggests clinical efficacy" 6 : 689-699, 2017

88 Qayyum, A. A., "Adipose-derived stromal cells for treatment of patients with chronic Ischemic Heart Disease(MyStromalCell Trial) : a randomized Placebo-controlled study" 2017 : 5237063-, 2017

89 Perin, E. C., "Adipose-derived regenerative cells in patients with ischemic cardiomyopathy : The PRECISE Trial" 168 : 88-95, 2014

90 Gutierrez-Fernandez, M., "Adipose tissue-derived stem cells in stroke treatment : from bench to bedside" 16 : 37-43, 2013

91 Zhu, H., "A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone" 5 : 550-560, 2010

92 Lee, J. S., "A long-term follow-up study of intravenous autologous mesenchymal stem cell transplantation in patients with ischemic stroke" 28 : 1099-1106, 2010

93 Gupta, P. K., "A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia" 11 : 143-, 2013

94 Chung, C. S., "A comparison of neurosphere differentiation potential of canine bone marrow-derived mesenchymal stem cells and adipose-derived mesenchymal stem cells" 75 : 879-886, 2013